Febrile neutropenia: a critical review of the initial management.
The present state of the art for management of patients with febrile neutropenia has been reviewed as well as potential ways to improve it in the future. A major advance has been the possibility to predict, accurately and early, the risk of complications and death in those patients. While the algorithm for therapy in low-risk patients is presently straightforward, significant progresses are needed for patients who are at higher risk of presenting severe complications.
Klastersky
Jean
J
Department of Medicine, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium. jean.klastersky@bordet.be
Awada
Ahmad
A
Paesmans
Mariane
M
Aoun
Mickael
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology
D000900:Anti-Bacterial Agents